We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Archrock
AROC
$6.72B
| $4.08M | 0.59% |
509,317
+174,404
| +52% | +$969K |
|
|
AVP
2
DELISTED
Avon Products, Inc.
AVP
| $3.21M | 0.46% |
668,197
+604,889
| +955% | +$2.16M |
|
3
Insight Enterprises
NSIT
$3.56B
| $3.1M | 0.45% |
108,383
+71,754
| +196% | +$1.81M |
|
|
MGLN
4
DELISTED
Magellan Health Services, Inc.
MGLN
| $3.06M | 0.44% |
45,084
-42,252
| -48% | -$2.54M |
|
|
EVDY
5
DELISTED
Everyday Health, Inc.
EVDY
| $2.96M | 0.43% |
528,194
+59,529
| +13% | +$293K |
|
|
SPTN
6
DELISTED
SpartanNash
SPTN
| $2.91M | 0.42% |
96,015
-119,079
| -55% | -$2.81M |
|
|
ISLE
7
DELISTED
Isle of Capri Casinos Inc
ISLE
| $2.88M | 0.41% |
205,484
+130,457
| +174% | +$1.61M |
|
|
HSII
8
DELISTED
Heidrick & Struggles
HSII
| $2.81M | 0.41% |
118,693
+92,875
| +360% | +$2.25M |
|
9
Orthofix Medical
OFIX
$445M
| $2.81M | 0.4% |
67,599
-110,653
| -62% | -$4.34M |
|
|
GTS
10
DELISTED
Triple-S Management Corporation
GTS
| $2.77M | 0.4% |
117,071
-11,738
| -9% | -$263K |
|
11
SunCoke Energy
SXC
$738M
| $2.75M | 0.4% |
423,757
+412,042
| +3,517% | +$1.75M |
|
|
MDRX
12
DELISTED
Veradigm Inc. Common Stock
MDRX
| $2.75M | 0.4% |
208,071
-8,021
| -4% | -$105K |
|
|
TOWR
13
DELISTED
Tower International, Inc.
TOWR
| $2.7M | 0.39% |
99,273
-149,284
| -60% | -$3.48M |
|
|
PDLI
14
DELISTED
PDL BioPharma, Inc.
PDLI
| $2.65M | 0.38% |
795,409
-853,674
| -52% | -$2.66M |
|
15
TETRA Technologies
TTI
$1.34B
| $2.62M | 0.38% |
412,223
+197,664
| +92% | +$1.16M |
|
|
IVC
16
DELISTED
Invacare Corporation
IVC
| $2.6M | 0.37% |
197,237
+108,481
| +122% | +$1.54M |
|
|
IPHI
17
DELISTED
INPHI CORPORATION
IPHI
| $2.54M | 0.37% |
+76,161
| New | +$2.03M |
|
18
IDT Corp
IDT
$1.6B
| $2.49M | 0.36% |
226,062
+147,207
| +187% | +$1.33M |
|
|
AUTO
19
DELISTED
AutoWeb, Inc. Common Stock
AUTO
| $2.49M | 0.36% |
143,247
+2,138
| +2% | +$38.3K |
|
|
ELNK
20
DELISTED
EarthLink Holdings Corp.
ELNK
| $2.45M | 0.35% |
432,352
-302,548
| -41% | -$1.77M |
|
|
XLRN
21
DELISTED
Acceleron Pharma
XLRN
| $2.43M | 0.35% |
91,943
-18,858
| -17% | -$548K |
|
|
BBBY
22
Bed Bath & Beyond
BBBY
$491M
| $2.42M | 0.35% |
224,194
+41,158
| +22% | +$402K |
|
|
HSKA
23
DELISTED
Heska Corp
HSKA
| $2.4M | 0.35% |
84,385
-31,591
| -27% | -$1.05M |
|
24
Stride
LRN
$3.58B
| $2.39M | 0.34% |
241,974
+151,519
| +168% | +$1.43M |
|
25
SPX Corp
SPXC
$11B
| $2.39M | 0.34% |
159,138
-390,910
| -71% | -$4.18M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.